Nathaniel Jonathan Berky: New Protein-Binding Insight May Transform Personalised IVF
Nathaniel Jonathan Berky, Venture Architect, shared a post on LinkedIn:
“This is an important advance for reproductive health.
Understanding fertilisation at this molecular-mechanical level brings us closer to a truly personalised IVF journey in which fit-for-purpose treatment (rather than ‘unexplained’) can be identified within a failed cycle.
If this protein-binding mechanism can be verified in the clinic, it could shorten the trial and error aspect of treatment, improve IVF success rates, and change how we screen patients to prepare them for a cycle.
Switzerland is well placed for this next stage: we have good research (Basel, ETH-Department of Biosystems Science and Engineering (D-BSSE)), the biotech translation capacity, and a patient group who would expect evidence-based care than just fertility standard protocols.”
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Oct 29, 2026, 15:58Eric Lameignere: Can DNA Fragmentation in Cumulus Cells Predict ICSI Outcomes?
-
Oct 29, 2026, 15:50Saadat Hassan: Sperm Function Testing – Can Advanced Diagnostics Guide IVF and ICSI Selection?
-
Oct 29, 2026, 15:34Sara Spiro: Celebrating the Stories Members Have Trusted With at Maven Clinic – Here Is Mine
-
Oct 29, 2026, 15:31Dina Ibrahem: 0 Motility, 1 Critical Decision
-
Oct 29, 2026, 15:28AI and Automation in Fertility and Genomics: Pipeline or Pipe Dream? – ARCS
-
Oct 29, 2026, 15:26Michael Schindler: Large Networks or Small Centers – Who Delivers Better Care?
-
Oct 29, 2026, 15:24Denny Sakkas: Driving Innovation in Reproductive Medicine
-
Oct 29, 2026, 15:10From the President’s Gala to Booth 905 at ASRM 2026 – First Fertility
-
Oct 29, 2026, 15:04Proud to Spotlight Dr. Jannie Michielsen and the Expertise She Brings to Every Day – Sims IVF